Reimagining Drug Discovery Process with AI - Isomorphic Labs
Welcome to Isomorphic Labs. 0. a--up. none. 1. a--up. none. We’re a digital biology company, here to redefine drug discovery with the power of artificial intelligence. 2. a--up. a--h-150-100. 0. a--up. none. We believe there’s a fundamental symmetry in the universe between biology and information science.
About Us - Isomorphic Labs
Isomorphic Labs was born in 2021 to apply AI and computational methods to drug discovery, and transform the way medicine helps and heals people. We’re building on the AlphaFold breakthrough in active partnership with Google DeepMind, united together as members of the Alphabet family. And that makes us different.
AI制药“新玩家”！DeepMind兄弟公司来了…… - 知乎专栏
Isomorphic Labs的理念是：计算和AI方法能够帮助科学家们将他们的工作带到下一个水平，并大大加快药物发现过程。 未来，AI技术不仅将越来越多地用于分析数据，还将越来越多地用于构建复杂生物现象的强大预测和生成模型。
Isomorphic Labs - Wikipedia
Isomorphic Labs Limited [1] is a London-based company which uses artificial intelligence for drug discovery. [2] [3] [4] Isomorphic Labs was founded by Demis Hassabis, who also serves as the CEO. [5] [3] The company was incorporated on February 24, 2021 [1] and announced on November 4, 2021. [6]
Introducing Isomorphic Labs
Building on this advance, today, I'm thrilled to announce the creation of a new Alphabet company – Isomorphic Labs – a commercial venture with the mission to reimagine the entire drug discovery process from first principles with an AI-first approach and, ultimately, to model and understand some of the fundamental mechanisms of life.
Isomorphic Labs介绍 - 知乎 - 知乎专栏
2022年10月11日 · Isomorphic的使命是最重要的：利用人工智能加速药物发现，并最终为人类一些最具破坏性的疾病找到治疗方法。 原文由Isomorphic Labs发布于2021 年 11月 , 本文使用DeepL翻译自 https://www. isomorphiclabs.com/news room
DeepMind spin-off aims to halve drug discovery times following …
2024年1月10日 · Isomorphic Labs uses an AI platform to predict biochemical structures, which aids the creation of new drugs by recommending which potential compounds will have the desired impact in the body.
Isomorphic signs up Lilly, Novartis for $3bn AI drug hunt
2024年1月8日 · Isomorphic is getting $37.5 million upfront from Novartis to get the ball rolling on three undisclosed drug targets, along with research funding and another $1.2 billion in milestone payments...
如何评价 DeepMind 创始人宣布创立 AI 制药公司 Isomorphic Labs…
2021年11月5日 · 11 月 4 日，哈萨比斯宣布了 Alphabet 新公司 Isomorphic Labs 的成立。 这家名为 Isomorphic Laboratories 的新公司将致力于构建识别新药物的工具。 DeepMind 首席执行官哈萨比斯（Demis Hassabis）也将担任 Isomorphic 的首席执行官，两家公司将保持独立并在适当的时 …
Isomorphic Labs - LinkedIn
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach,...